Jing Yuan

Summary

Affiliation: Boehringer Ingelheim

Publications

  1. ncbi Toxicogenomics of nevirapine-associated cutaneous and hepatic adverse events among populations of African, Asian, and European descent
    Jing Yuan
    Non Clinical Drug Safety, Boehringer Ingelheim Pharmaceuticals Inc, Ridgefield, Connecticut 06877, USA
    AIDS 25:1271-80. 2011
  2. ncbi Rule based classifier for the analysis of gene-gene and gene-environment interactions in genetic association studies
    Thorsten Lehr
    Boehringer Ingelheim Pharma GmbH and Co, KG, Department of Drug Metabolism and Pharmacokinetics, 88397 Biberach an der Riss, Germany
    BioData Min 4:4. 2011

Detail Information

Publications2

  1. ncbi Toxicogenomics of nevirapine-associated cutaneous and hepatic adverse events among populations of African, Asian, and European descent
    Jing Yuan
    Non Clinical Drug Safety, Boehringer Ingelheim Pharmaceuticals Inc, Ridgefield, Connecticut 06877, USA
    AIDS 25:1271-80. 2011
    ..Nevirapine is widely prescribed for HIV-1 infection. We characterized relationships between nevirapine-associated cutaneous and hepatic adverse events and genetic variants among HIV-infected adults...
  2. ncbi Rule based classifier for the analysis of gene-gene and gene-environment interactions in genetic association studies
    Thorsten Lehr
    Boehringer Ingelheim Pharma GmbH and Co, KG, Department of Drug Metabolism and Pharmacokinetics, 88397 Biberach an der Riss, Germany
    BioData Min 4:4. 2011
    ..abstract:..